Rein Therapeutics Inc.
- RNTX
- NASDAQ
- Biotechnology
- Oncology Biotech
- Peptide Therapeutics
$0.59
Today −6.00%Quote Oct 16, 2026, 08:00 PM UTC
−25.20%over the last month
Max drawdown −31.2%From 1-month high −30.7%3 months −30.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$50.9M
Quote Oct 16
Next earnings
Nov 13
Expected, not confirmed
Analyst target
$6.00
+916.4% from here
Floor
$0.54
8.5% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about RNTXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
10